Search Results

Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy

• Authors : Gujar, Shashi; Pol, Jonathan G.; Kumar, Vishnupriyan

• Source: Nature Protocols; September 2024, Vol. 19 Issue: 9 p2540-2570, 31p

Record details

Boarding Oncolytic Viruses onto Tumor-Homing Bacterium-Vessels for Augmented Cancer Immunotherapy.

• Authors : Sun, Mengchi; Yang, Shihua; Huang, Hanwei

• Source: Nano Letters; 6/22/2022, Vol. 22 Issue 12, p5055-5064, 10p

Record details

Exosomes as a drug delivery tool for cancer therapy: a new era for existing drugs and oncolytic viruses

• Authors : Kakiuchi, Yoshihiko; Kuroda, Shinji; Kanaya, Nobuhiko

• Source: Expert Opinion on Therapeutic Targets; September 2023, Vol. 27 Issue: 9 p807-816, 10p

Record details

Extracellular Vesicles: a Trojan Horse Delivery Method for Systemic Administration of Oncolytic Viruses

• Authors : Taheri, Behnaz; Zarei-Behjani, Zeinab; Babaei, Abouzar

• Source: Regenerative Engineering and Translational Medicine; 20230101, Issue: Preprints p1-11, 11p

Record details

Therapy with oncolytic viruses: progress and challenges

• Authors : Shalhout, Sophia Z.; Miller, David M.; Emerick, Kevin S.

• Source: Nature Reviews Clinical Oncology; March 2023, Vol. 20 Issue: 3 p160-177, 18p

Record details

Development of oncolytic viruses for cancer therapy.

• Authors : Abd-Aziz, Noraini; Poh, Chit Laa

• Source: Translational Research: The Journal of Laboratory & Clinical Medicine; Nov2021, Vol. 237, p98-123, 26p

Record details

Researchers Submit Patent Application, "Oncolytic Viruses For Modified Mhc Expression", for Approval (USPTO 20240277793).

• Source: Vaccine Weekly; 9/13/2024, p205-205, 1p

Record details

Patent Issued for Oncolytic viruses for modified MHC expression (USPTO 12016893).

• Source: Vaccine Weekly; 7/19/2024, p155-155, 1p

Record details

Clinical Trials of Oncolytic Viruses in Glioblastoma

• Authors : Shoaf, Madison L.; Peters, Katherine B.

• Source: Advances in Oncology; May 2022, Vol. 2 Issue: 1 p139-158, 20p

Record details

"Oncolytic Viruses For Modified Mhc Expression" in Patent Application Approval Process (USPTO 20240277794).

• Source: Vaccine Weekly; 9/13/2024, p93-93, 1p

Record details